In Vitro Susceptibility of Clostridium difficile Isolates to Cefotaxime, Moxalactam, and Cefoperazone
- 1 May 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (5), 846-847
- https://doi.org/10.1128/aac.21.5.846
Abstract
The in vitro susceptibility of 20 isolates of Clostridium difficile to cefotaxime, moxalactam, and cefoperazone was determined by a standard agar dilution method. The median minimal inhibitory concentrations were 64, 32, and 32 μg/ml for cefotaxime, moxalactam, and cefoperazone, respectively.Keywords
This publication has 13 references indexed in Scilit:
- Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1981
- Evaluation of eight cephalosporins in hamster colitis modelAntimicrobial Agents and Chemotherapy, 1981
- Pharmacokinetics of moxalactam in subjects with normal and impaired renal functionAntimicrobial Agents and Chemotherapy, 1981
- Moxalactam therapy for a wide spectrum of bacterial infections in adultsAntimicrobial Agents and Chemotherapy, 1981
- Worldwide Clinical Experience with CefoperazoneDrugs, 1981
- Pharmacokinetics of CefoperazoneDrugs, 1981
- In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitisAntimicrobial Agents and Chemotherapy, 1980
- Human Pharmacology of Cefotaxime (HR 756), a New CephalosporinAntimicrobial Agents and Chemotherapy, 1979
- Cephalosporin-associated pseudomembranous colitisDigestive Diseases and Sciences, 1978